![]()
2024 ASCO Annual Meeting
2024 ASCO Annual Meeting
Oral Abstract Session
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
June 1 – 3:00 PM CDT
location_onHall D1
2024 ASCO Annual Meeting
Rapid Oral Abstract Session
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Primary Track: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
June 3 – 8:00 AM CDT
location_onS406
Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial.
8:12 AM CDTJia (Jenny) Liu, MD, PhDAbstract 3014
- Forums
- ASX - By Stock
- ASCO Presentations 2024
SPL
starpharma holdings limited
Add to My Watchlist
4.17%
!
12.5¢

[IMG] 2024 ASCO Annual Meeting 2024 ASCO Annual Meeting Oral...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
12.5¢ |
Change
0.005(4.17%) |
Mkt cap ! $52.27M |
Open | High | Low | Value | Volume |
12.0¢ | 12.5¢ | 12.0¢ | $5.14K | 42.72K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 42106 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 74086 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 42106 | 0.115 |
1 | 4650 | 0.110 |
2 | 126900 | 0.105 |
5 | 543009 | 0.100 |
1 | 30303 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 74086 | 1 |
0.130 | 323620 | 3 |
0.135 | 230549 | 8 |
0.140 | 155336 | 3 |
0.145 | 13227 | 4 |
Last trade - 16.10pm 15/09/2025 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman and CEO
Hank Holland
Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online